11 November 2014
A new treatment regimen for hepatitis C, the most common cause of liver cancer and transplantation, has produced results that will transform treatment protocols for transplant patients, according to research.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/bCXtHXdFauI/141111092724.htm
